Phytonadione
NDC Package 68682-170-30
Package Information
Phytonadione is vitamin K is used to treat and prevent low levels of certain substances (blood clotting factors) that your body naturally produces. Marketed by Oceanside Pharmaceuticals, this product is identified by NDC 68682-170 and is authorized under FDA application NDA010104.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 68682 - Oceanside Pharmaceuticals
- 68682-170 - Phytonadione
- 68682-170-30 - 1 BOTTLE in 1 CARTON / 30 TABLET in 1 BOTTLE
- 68682-170 - Phytonadione
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (68682-170). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68682-170-30 identifies a specific commercial package of 1 bottle in 1 carton / 30 tablet in 1 bottle of Phytonadione, labeled by Oceanside Pharmaceuticals. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Oceanside Pharmaceuticals on April 23, 2018. The current certification is valid through October 01, 2022.
What are the primary indications for this medication?
Vitamin K is used to treat and prevent low levels of certain substances (blood clotting factors) that your body naturally produces. These substances help your blood to thicken and stop bleeding normally (such as after an accidental cut or injury). Low levels of blood clotting factors increase the risk for unusual bleeding. Low levels may be caused by certain medications (such as warfarin) or medical conditions (such as obstructive jaundice). Vitamin K helps to treat and prevent unusual bleeding by increasing the body's production of blood clotting factors.
How is this Oceanside Pharmaceuticals product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68682017030. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.